Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating satralizumab for Thyroid Eye Disease, with the study currently listed as ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• Enspryng (satralizumab) (satralizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Thyroid Eye Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING